GeneDx is trading at $100.36, down -4.37%, after a sharp multi-session advance, with profit-taking or positioning possibly contributing.
- GeneDx gained 7.73% on September 17.
- No clear company-specific announcement, earnings update, analyst action, or regulatory catalyst was identified for September 18, 2026.
- GeneDx’s investor-relations release page shows no newer relevant company announcement after September 10. Broader indexes are modestly lower but offer no strong standalone explanation.